Format

Send to

Choose Destination
Rheum Dis Clin North Am. 2008 Feb;34(1):181-90; viii. doi: 10.1016/j.rdc.2007.12.002.

The heart in scleroderma.

Author information

1
Division of Cardiology, Department of Medicine, The Johns Hopkins Medical Institutions, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 850, Baltimore, MD 21205, USA. hcc@jhmi.edu

Abstract

The heart is one of the major organs involved in scleroderma, the involvement of which can be manifested by myocardial disease, conduction system abnormalities, arrhythmias, or pericardial disease. Additionally, scleroderma renal crisis and pulmonary hypertension lead to significant cardiac dysfunction secondary to damage in the kidney and lung. This article summarizes the types and mechanism of abnormalities in the heart in scleroderma. The concept of cardiac dysfunction in scleroderma and other rheumatologic conditions has received new interest with the advent of newer noninvasive imaging techniques, as well as the interest in detecting subclinical disease. With this increased interest in cardiac manifestations in scleroderma comes the realization that long-term studies are needed to better assess the appropriate screening and treatment in this patient population.

PMID:
18329539
PMCID:
PMC2361099
DOI:
10.1016/j.rdc.2007.12.002
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center